Buy PG Stock Over Colgate-Palmolive?

Core Viewpoint - Procter & Gamble (P&G) stock is currently viewed favorably, especially in comparison to its competitor Colgate-Palmolive (CL), despite both companies experiencing a decline of approximately 12% year-to-date, while the S&P 500 has increased by 16% [2][3]. Financial Performance Comparison - P&G's recent quarterly revenue growth was 3.0%, significantly higher than CL's 1.0% [4]. - On a trailing twelve-month basis, P&G's revenue growth stands at 1.2%, compared to CL's 0.1% [4]. - P&G demonstrates superior profitability with a last twelve-month operating margin of 24.1% and a three-year average margin of 23.6%, both of which exceed CL's corresponding figures [4]. Investment Strategy Insights - For investors seeking potential gains with reduced volatility, a High Quality Portfolio is recommended, which has consistently outperformed its benchmark, yielding returns exceeding 105% since its launch [5]. - The performance metrics of the High Quality Portfolio illustrate that it has generated better returns with less risk compared to the benchmark index [5].